Get people to treatment early and increase awareness that the disease is completely curable. This is the firm route to eradicate tuberculosis (TB), according to Mr Mike Mandelbaum, Chief Executive, TB Alert, UK.
Though 1.7 million people worldwide die to TB annually and India has the dubious distinction of accounting for 4 lakh of them, TB can be prevented and cured with proper adherence to regimen, he told newspersons here today.
There are also encouraging research studies pointing to development of preventive vaccines, better drugs which can shorten the duration of treatment time from the present (6-8 months) in the future, Mr Mike said.
Participating in the 'Speak up to stop TB' initiative launched here jointly by REACH and the Lilly MDR TB partnership, Mr Mike said though two billion people have the TB bacteria latent, the chances of contracting the commonest lung TB is as low as 10 per cent. He felt that TB should now be referred to more as an 'illness' than a disease as it is easily treatable.
The Lilly MDR TB partnership, a public-private initiative, has mobilised 18 partners in five continents to fight the battle to stop spread of TB. Lilly is donating $135 million.
Dr Ramya Ananthakrishnan, Medical Co-ordinator for REACH, said there was still stigma attached to TB patients in society. This was uncalled for because TB can affect anyone. Also, it can be treated with available drugs and the Government provides them free of cost in India.
Dr Nalini Krishnan, Executive Secretary of REACH (Resource Group for Education & Advocacy for Community Health), a Chennai-based public-private initiative focused on TB control, also announced the launch of a Web site that provides a range of information about TB (
www.media4tb.org).